We found that tumor-associated GCSF reduced the number of tumor-resident cDC1s in the breast cancer model, and in the colon cancer model there was a trend toward reduced cDC1s in colons of isotype versus anti-GCSF Ab-treated mice. The gene discussed is CSF3; the disease is neoplasm.